Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant

Bone Marrow Transplantation

Volumn 40, Issue 3, 2007, Pages 201-208

  Liao, C ^a   Wu, J Y ^a   Xu, Z P ^a   Li, Y ^a   Yang, X ^a   Chen, J S ^a   Tang, X W ^a   Gu, S L ^a   Huang, Y N ^a   Tang, P H ^b   Tsang, K S ^c  

^a GUANGZHOU MATERNAL AND NEONATAL HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLELE; ARTICLE; CHILD; CHINESE; CORD BLOOD STEM CELL TRANSPLANTATION; CORRELATION ANALYSIS; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA TYPING; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OLIGONUCLEOTIDE PROBE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHINA; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; MALE; METABOLIC DISEASES; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE;

EID: 34547203014     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705711     Document Type: Article

References (27)

1. Wernet P. The Netcord inventory and use [Netcord web site] October 2006. Available at: https://www.netcord.org/inventory.html. Accessed on February 16, 2007.
2. Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001; 345 1794-1800.
3. Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206.
4. Flomenberg N, Baxter-Lowe LA. Confer D, Fernandez-Vina M, Filipovich A, Horowitz M et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930.
5. Greinix HT, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35: 57-62.
6. Giebel S, Giorgiani G, Martinetti M, Zecca M, Maccario R, Salvaneschi L et al. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003; 31: 987-993.
7. Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J et al. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006; 37: 909-916.
8. Kogler G, Enczmann J, Rocha V, Gluckman E, Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005; 36: 1033-1041.
9. Wu JY, Liao C, Xu ZP, Chen JS, Gu SL, Huang YN et al. Banking and transplantation of umbilical cord blood in Guangzhou, China. Cytotherapy 2006; 8: 488-497.
10. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
11. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow Transplant 2006; 38: 83-93.
12. Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH et al. Impact of HLA-A, B, C allele mismatches on outcome after unrelated blood stem cell transplantation in whites. Transplantation 2004; 78: 1077-1080.
13. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
14. Ooi J, Iseki T, Takahashi S, Tomonari A, Nagayama H, Ishii K et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haemnatol 2002; 118: 140-143.
15. Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragan E et al. Standardized unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332-2338.
16. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
17. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al. Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004; 32 397-407.
18. La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G et al. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005; 1054: 186-195.
19. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
20. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351 2276-2285.
21. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: A Eurocord Group analysis. Blood 2003; 102: 4290-4297.
22. Krampera M, Tavecchia L, Benedetti F, Nadah G, Pizzolo G. Intracellular cytokine profile of cord blood T-, and NK-cells and monocytes. Haematologica 2000; 85: 675-679.
23. Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, Kurtzberg J. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003; 31: 708-714.
24. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586-3592.
25. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
26. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942-2947.
27. Hawkins BR, Dunbar MM, Liang R, Chin E, Lie A, Chan TK. Probability of finding a matched donor for bone marrow transplantation in a Chinese population: Two year experience of an all-Chinese marrow donor registry. Transplant Proc 1995; 27: 1375-1376.